Adamas Pharmaceuticals reported 21.82M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 95.33M 14.04M
Adamas Pharmaceuticals ADMS:US 21.82M 7.35M
Aerie Pharmaceuticals AERI:US $ 108.09M 14.72M
Aptinyx Inc APTX:US $ 3.38M 496K
Flexion Therapeutics FLXN:US $ 39.93M 18.05M
GlaxoSmithKline GSK:LN 21387M 1112M
Glaxosmithkline GSK:US $ 21387M 1112M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Intra Cellular Therapies ITCI:US $ 50.42M 10.72M
Marinus Pharmaceuticals MRNS:US $ 16.69M 0.57M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NOVN:VX SF 29633M 527M
Omeros OMER:US $ 47.7M 4.26M
Prothena PRTA:US 52.9M 29.44M
Revance Therapeutics RVNC:US $ 58.25M 7.41M
Teva Pharmaceutical TEVA:IT 12.69B 602M
Zogenix ZGNX:US $ 69.34M 10.81M